ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe ...

Ilia Malinin’s Olympic collapse shows how performance culture can turn achievement into a search for belonging, and why that pressure can eventually overwhelm even the best.

Yes, it is protest season—because students are turned away, and their hope refuses to fade or be redirected. All they ask for ...

(NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today issued the following statement in response to the Schedule 13 D filed by Commonwealth Asset Management: Innventure’s Board of ...

Europe is moving to stricter age limits on social media. This article investigates the rationale behind the push, the ...

VANCOUVER, BC / ACCESS Newswire / / Roxmore Resources Inc. (formerly, Axcap Ventures Inc.) (TSX:RM)(OTCQX:GARLF) ("Roxmore" ...

It took years to see that I wasn't just being nice or considerate. I was still trying to please my parents through every ...

The European experience of dependence on US guarantees in many ways resembles the familiar decline in quality of digital ...

Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to ...

PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Thursday, February 26, 2026 to provide an update on recent corporate ...

Donnelley Financial Solutions, Inc. (NYSE: DFIN) (the "Company" or "DFIN") today reported financial results for the fourth quarter and full year of 2025.

Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first lin ...